Rex Genia Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.59 M
- Company Age 8 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 9.50 M
- Revenue Growth -10.66%
- Profit Growth 31.34%
- Ebitda -28.09%
- Net Worth 33.41%
- Total Assets 13.98%
About Rex Genia Life Sciences
Rex Genia Life Sciences Private Limited (RGLSPL) is a Private Limited Indian Non-Government Company incorporated in India on 30 April 2016 (Eight years and nine months 26 days old ). Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.59 M.
The company has closed loans amounting to ₹9.50 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Parvatamma Basapuram, Sale Ram, and Kurva Raghavendraprasad serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24230MH2016PTC280451
- Company No.
280451
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Apr 2016
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Rex Genia Life Sciences?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Parvatamma Basapuram  | Director | 30-Apr-2016 | Current |
| Sale Ram | Director | 09-Dec-2020 | Current |
| Kurva Raghavendraprasad | Director | 28-Feb-2022 | Current |
Financial Performance of Rex Genia Life Sciences.
Rex Genia Life Sciences Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 10.66% decrease. The company also saw a substantial improvement in profitability, with a 31.34% increase in profit. The company's net worth Soared by an impressive increase of 33.41%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rex Genia Life Sciences?
In 2023, Rex Genia Life Sciences had a promoter holding of 85.47% and a public holding of 14.53%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Surakshitha Healthcare Private LimitedParvatamma Basapuram is a mutual person
Charges (Loans)
₹0
₹9.50 M
Charges Breakdown by Lending Institutions
- State Bank Of India : 0.95 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 Mar 2017 | State Bank Of India | ₹9.50 M | Satisfied |
How Many Employees Work at Rex Genia Life Sciences?
Rex Genia Life Sciences has a workforce of 0 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rex Genia Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rex Genia Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
